Vigeo Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2011-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors
- First Posted Date
- 2017-12-06
- Last Posted Date
- 2023-05-15
- Lead Sponsor
- Vigeo Therapeutics, Inc.
- Target Recruit Count
- 116
- Registration Number
- NCT03364400
- Locations
- 🇺🇸
Florida Cancer Specialists, Sarasota, Florida, United States
🇺🇸Northwestern Memorial Hospital, Chicago, Illinois, United States
🇺🇸Horizon Oncology Center, Lafayette, Indiana, United States
News
No news found